For COVID-19 vaccine updates, please review our information guide. For patient eligibility and scheduling availability, please visit VaccineTogetherNY.org.

You are here

Publications

Found 71 results
Author Title [ Type(Asc)] Year
Filters: Author is Ma, Xiaojing  [Clear All Filters]
Journal Article
Shi X, Liu J, Xiang Z, Mitsuhashi M, Wu RS, Ma X.  2004.  Gene expression analysis in Interleukin-12-induced suppression of mouse mammary carcinoma.. Int J Cancer. 110(4):570-8.
Wang C, Li Y, Chu C-M, Zhang X-M, Ma J, Huang H, Wang Y-N, Hong T-Y, Zhang J, Pan X-W et al..  2019.  Gankyrin is a novel biomarker for disease progression and prognosis of patients with renal cell carcinoma.. EBioMedicine. 39:255-264.
Murray HW, Luster AD, Zheng H, Ma X.  2017.  Gamma Interferon-Regulated Chemokines in Leishmania donovani Infection in the Liver.. Infect Immun. 85(1)
Park-Min K-H, Serbina NV, Yang W, Ma X, Krystal G, Neel BG, Nutt SL, Hu X, Ivashkiv LB.  2007.  FcgammaRIII-dependent inhibition of interferon-gamma responses mediates suppressive effects of intravenous immune globulin.. Immunity. 26(1):67-78.
Yin F, Banerjee R, Thomas B, Zhou P, Qian L, Jia T, Ma X, Ma Y, Iadecola C, M Beal F et al..  2010.  Exaggerated inflammation, impaired host defense, and neuropathology in progranulin-deficient mice.. J Exp Med. 207(1):117-28.
Zhang L, Adileh M, Martin MLaura, Klingler S, White J, Ma X, Howe LR, Brown AMC, Kolesnick R.  2017.  Establishing estrogen-responsive mouse mammary organoids from single Lgr5 cells.. Cell Signal. 29:41-51.
Liao L, Song M, Li X, Tang L, Zhang T, Zhang L, Pan Y, Chouchane L, Ma X.  2017.  E3 Ubiquitin Ligase UBR5 Drives the Growth and Metastasis of Triple-Negative Breast Cancer.. Cancer Res. 77(8):2090-2101.
Torroella-Kouri M, Ma X, Perry G, Ivanova M, Cejas PJ, Owen JL, Iragavarapu-Charyulu V, Lopez DM.  2005.  Diminished expression of transcription factors nuclear factor kappaB and CCAAT/enhancer binding protein underlies a novel tumor evasion mechanism affecting macrophages of mammary tumor-bearing mice.. Cancer Res. 65(22):10578-84.
Liu J, Cao S, Herman LM, Ma X.  2003.  Differential regulation of interleukin (IL)-12 p35 and p40 gene expression and interferon (IFN)-gamma-primed IL-12 production by IFN regulatory factor 1.. J Exp Med. 198(8):1265-76.
Cao S, Liu J, Chesi M, Bergsagel PLeif, Ho I-C, Donnelly RP, Ma X.  2002.  Differential regulation of IL-12 and IL-10 gene expression in macrophages by the basic leucine zipper transcription factor c-Maf fibrosarcoma.. J Immunol. 169(10):5715-25.
Murray HW, Moreira AL, Lu CM, DeVecchio JL, Matsuhashi M, Ma X, Heinzel FP.  2003.  Determinants of response to interleukin-10 receptor blockade immunotherapy in experimental visceral leishmaniasis.. J Infect Dis. 188(3):458-64.
Noguchi E, Homma Y, Kang X, Netea MG, Ma X.  2009.  A Crohn's disease-associated NOD2 mutation suppresses transcription of human IL10 by inhibiting activity of the nuclear ribonucleoprotein hnRNP-A1.. Nat Immunol. 10(5):471-9.
Hu W, Zi Z, Jin Y, Li G, Shao K, Cai Q, Ma X, Wei F.  2019.  CRISPR/Cas9-mediated PD-1 disruption enhances human mesothelin-targeted CAR T cell effector functions.. Cancer Immunol Immunother. 68(3):365-377.
Jiao X, Katiyar S, Willmarth NE, Liu M, Ma X, Flomenberg N, Lisanti MP, Pestell RG.  2010.  c-Jun induces mammary epithelial cellular invasion and breast cancer stem cell expansion.. J Biol Chem. 285(11):8218-26.
Liu J, Malkani G, Mankani G, Shi X, Meyer M, Cunningham-Runddles S, Ma X, Sun ZSheng.  2006.  The circadian clock Period 2 gene regulates gamma interferon production of NK cells in host response to lipopolysaccharide-induced endotoxic shock.. Infect Immun. 74(8):4750-6.
Lv D, Zhang Y, Kim H-J, Zhang L, Ma X.  2013.  CCL5 as a potential immunotherapeutic target in triple-negative breast cancer.. Cell Mol Immunol. 10(4):303-10.
Wang H, Wang C, Peng G, Yu D, Cui X-G, Sun Y-H, Ma X.  2020.  Capping Protein Regulator and Myosin 1 Linker 3 Is Required for Tumor Metastasis.. Mol Cancer Res. 18(2):240-252.
Murray HW, Flanders KC, Donaldson DD, Sypek JP, Gotwals PJ, Liu J, Ma X.  2005.  Antagonizing deactivating cytokines to enhance host defense and chemotherapy in experimental visceral leishmaniasis.. Infect Immun. 73(7):3903-11.
Tripathi P, Madan R, Chougnet C, Divanovic S, Ma X, Wahl LM, Gajewski T, Karp CL, Hildeman DA.  2006.  An adenoviral vector for probing promoter activity in primary immune cells.. J Immunol Methods. 311(1-2):19-30.
Luo Q, Ma X, Wahl SM, Bieker JJ, Crossley M, Montaner LJ.  2004.  Activation and repression of interleukin-12 p40 transcription by erythroid Kruppel-like factor in macrophages.. J Biol Chem. 279(18):18451-6.
Ban Y, Dong W, Zhang L, Zhou T, Altiti AS, Ali K, Mootoo DR, Blaho VA, Hla T, Ren Y et al..  2019.  Abrogation of Endogenous Glycolipid Antigen Presentation on Myelin-Laden Macrophages by D-Sphingosine Ameliorates the Pathogenesis of Experimental Autoimmune Encephalomyelitis.. Front Immunol. 10:404.